New heart valve fix tested without cutting chest open
NCT ID NCT06038838
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new device called the Tioga TMVR System to treat a leaky heart valve (mitral regurgitation) without open-heart surgery. It will include 30 people with moderate to severe symptoms who are not good candidates for surgery. The main goals are to see if the device is safe and can be placed correctly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MITRAL REGURGITATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Helsicore Hospital (Israeli Georgeian Medical Research Clinic Healthycore)
RECRUITINGTbilisi, Georgia
-
Incor - Instituto do Coração do Hospital das Clínicas da FMUSP
RECRUITINGSão Paulo, Brazil
-
Sanatorio Italiano
RECRUITINGAsunción, Paraguay
-
Tbilisi Heart and Vascular Clinic
RECRUITINGTbilisi, Georgia
-
Vilnius Univ. Hospital
RECRUITINGVilnius, Lithuania
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI ultrasound could unmask silent heart disease in seniors
- Can a new valve device fix a leaky heart without open surgery?
- Can mixed reality make heart valve surgery safer and faster?
- A painless, contact-free vibration sensor may detect hidden heart and lung problems
- New heart valve device could spare High-Risk patients from Open-Heart surgery
- First-in-Human trial aims to offer new hope for patients with leaky heart valves who Can't have surgery